Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway

Li,Shenglei; Li,Xin; Zhao,Huasi; Gao,Ming; Wang,Feng; Li,Wencai

doi:10.3892/mmr.2015.4038

Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway

Authors:
- Shenglei Li
- Xin Li
- Huasi Zhao
- Ming Gao
- Feng Wang
- Wencai Li
View Affiliations

Affiliations: Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
Published online on: July 3, 2015 https://doi.org/10.3892/mmr.2015.4038
Pages: 5482-5486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRs) are a family of small non-coding RNAs that are 21‑24 nucleotides in length. Decreased expression of hsa‑miR‑125a‑3p is observed in a number of patients with non‑small cell lung cancer; however, it is not clear how this miRNA regulates the growth and invasion of lung tumor cells. The aim of the present study was to identify the function of hsa‑miR‑125a‑3p in the growth and invasion of lung cancer cells. The expression of hsa‑miR‑125a‑3p in the A549, NCI‑H460 and SPCA‑1 lung cancer cell lines was analyzed by reverse transcription‑quantitative polymerase chain reaction and the human bronchiolar epithelium cell line (HBE) was used as a control. The results demonstrated that the expression of hsa‑miR‑125a‑3p was significantly lower in NCI‑H460, A549 and SPCA‑1 cells, compared with that in HBE cells. Overexpression of sense miR‑125a‑3p in the A549 lung cancer cell line inhibited cell proliferation for 5‑7 days (P<0.01), and transfection of antisense miR‑125a‑3p did not suppress the cell growth of the lung cancer cells. In addition, overexpression of miR‑125a‑3p in the NCI‑H460 lung cancer cell line markedly induced cell apoptosis, which was detected by fluorescence‑activated cell sorting with annexin V‑fluorescein isothiocyanate/propidium iodide staining. The results of the Transwell migration assay also revealed that transfection of miR‑125a‑3p resulted in decreased migration of lung cancer tumor cells. The pro‑apoptotic gene p53 expression was detected by western blot analysis. The results revealed that the expression of mouse double minute (MDM)‑2 homolog, the principal cellular antagonist of p53, was decreased and p53 expression was upregulated in sense has‑miR‑125a‑3p transfected A549 cells. This was consistent with that observed in NCI‑H460 cells, suggesting that hsa‑miR‑125a‑3p may be involved in the regulation of the MDM2/p53 signaling pathway in lung cancer cells. In conclusion, overexpression of hsa‑miR‑125a‑3p significantly inhibited the proliferation and invasion of lung cancer cells, which may aid in determining the mechanisms underlying the development of lung cancer.

View Figures

View References

1	Xu X, Yang X, Xing C, Zhang S and Cao J: miRNA: The nemesis of gastric cancer (Review). Oncol Lett. 6:631–641. 2013.PubMed/NCBI
2	Cai Y, Yu X, Hu S and Yu J: A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 7:147–154. 2009. View Article : Google Scholar
3	Lodewijk L, Prins AM, Kist JW, et al: The value of miRNA in diagnosing thyroid cancer: a systematic review. Cancer Biomark. 11:229–238. 2012.PubMed/NCBI
4	Srivastava K and Srivastava A: Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS ONE. 7:e509662012. View Article : Google Scholar : PubMed/NCBI
5	Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 282:1479–1486. 2007. View Article : Google Scholar
6	Jiang L, Zhang Q, Chang H, Qiu X and Wang E: hsa-miR-125a-5p enhances invasion in non-small cell lung carcinoma cell lines by upregulating rock-1. Zhongguo Fei Ai Za Zhi. 12:1069–1073. 2009.In Chinese.
7	Huang B, Luo W, Sun L, et al: MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Int J Oncol. 42:1734–1742. 2013.PubMed/NCBI
8	Li X, Sundquist J, Zöller B and Sundquist K: Neighborhood deprivation and lung cancer incidence and mortality: a multilevel analysis from sweden. J Thorac Oncol. 10:256–263. 2015. View Article : Google Scholar
9	Janković M, Samarzija M, Jakopović M, Kulis T and Znaor A: Trends in lung cancer incidence and mortality in Croatia, 1988–2008. Croat Med J. 53:93–99. 2012. View Article : Google Scholar
10	Ondrusova M, Muzik J, Hunakova L, et al: Trends in the lung cancer incidence and mortality in the Slovak and Czech Republics in the contexts of an international comparison. Clin Transl Oncol. 659–666. 2012. View Article : Google Scholar : PubMed/NCBI
11	Song Y and Yao Y: Lung cancer screening:review and prospect. Zhonghua Jie He He Hu Xi Za Zhi. 37:164–166. 2014.In Chinese. PubMed/NCBI
12	Pendharkar D, Ausekar BV and Gupta S: Molecular biology of lung cancer-a review. Indian J Surg Oncol. 4:120–124. 2013. View Article : Google Scholar :
13	Di JZ, Peng JY and Wang ZG: Prevalence, clinicopathological characteristics, treatment, and prognosis of intestinal metastasis of primary lung cancer: A comprehensive review. Surg Oncol. 23:72–80. 2014. View Article : Google Scholar : PubMed/NCBI
14	Thunnissen E, van der Oord K and den Bakker M: Prognostic and predictive biomarkers in lung cancer. A review Virchows Arch. 464:347–358. 2014. View Article : Google Scholar
15	Kumar S, Mohan A and Guleria R: Prognostic implications of circulating anti-p53 antibodies in lung cancer - a review. Eur J Cancer Care (Engl). 18:248–254. 2009. View Article : Google Scholar
16	Bergqvist M: Radiosensitivity in lung cancer with focus on p53: a review based on a doctoral thesis. Ups J Med Sci. 108:87–127. 2003.PubMed/NCBI
17	Wang AL, Liu ZX, Li G and Zhang LW: Expression and significance of P53 protein and MDM-2 protein in human gliomas. Chin Med J (Engl). 124:2530–2533. 2011.
18	Asher G, Lotem J, Sachs L, Kahana C and Shaul Y: Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA. 99:13125–13130. 2002. View Article : Google Scholar : PubMed/NCBI
19	Jabbur JR, Tabor AD, Cheng X, et al: Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21. Oncogene. 21:7100–7113. 2002. View Article : Google Scholar : PubMed/NCBI
20	Almog N, Milyavsky M, Stambolsky P, Falcovitz A, Goldfinger N and Rotter V: The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop. Carcinogenesis. 22:779–785. 2001. View Article : Google Scholar : PubMed/NCBI
21	Kondo I, Iida S, Takagi Y and Sugihara K: MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer. Dis Colon Rectum. 51:1395–1402. 2008. View Article : Google Scholar : PubMed/NCBI
22	Nishitani H, Sugimoto N, Roukos V, et al: Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25:1126–1136. 2006. View Article : Google Scholar : PubMed/NCBI
23	Peng L, Xu Z, Zhou Y, Yang T, Liang ZQ and Zhang M: Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line. Zhonghua Gan Zang Bing Za Zhi. 18:148–149. 2010.In Chinese. PubMed/NCBI
24	Schulman BA, Carrano AC, Jeffrey PD, et al: Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature. 408:381–386. 2000. View Article : Google Scholar : PubMed/NCBI
25	Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 66:188–193. 1975. View Article : Google Scholar : PubMed/NCBI
26	Buchegger F, Dupertuis YM and Perillo-Adamer F: A pitfall of propidium iodide staining in fluorescence-activated cell sorting cell cycle analysis? Cancer Res. 67:5576–5577. 2007. View Article : Google Scholar : PubMed/NCBI
27	Rüster B, Grace B, Seitz O, Seifried E and Henschler R: Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay. Stem Cells Dev. 14:231–235. 2005. View Article : Google Scholar : PubMed/NCBI
28	Primiceri E, Chiriacò MS, Dioguardi F, et al: Automatic transwell assay by an EIS cell chip to monitor cell migration. Lab Chip. 11:4081–4086. 2011. View Article : Google Scholar : PubMed/NCBI
29	Tilghman SL, Rhodes LV, Bratton MR, et al: Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancer. J Health Care Poor Underserved. 24(Suppl): 36–46. 2013. View Article : Google Scholar : PubMed/NCBI
30	Kim JK, Noh JH, Jung KH, et al: Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 57:1055–1067. 2013. View Article : Google Scholar
31	Jiang L, Huang Q, Chang J, Wang E and Qiu X: MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res. 37:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
32	Bi Q, Tang S, Xia L, et al: Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS ONE. 7:e401692012. View Article : Google Scholar : PubMed/NCBI
33	Hashiguchi Y, Nishida N, Mimori K, et al: Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol. 40:1477–1482. 2012.PubMed/NCBI
34	Collins J, Noble S, Chester J, Coles B and Byrne A: The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open. 4:e0036972014. View Article : Google Scholar : PubMed/NCBI